Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
BMJ Open|September 19, 2014
Rates and predictors of ACE inhibitor discontinuation subsequent to elevated serum creatinine: a retrospective cohort studyCynthia A Jackevicius, Joyce Wong, Irina Aroustamian, et al.
Pharmacotherapy|September 10, 2019
Evaluation of Patients with Heart Failure to Determine Eligibility for Treatment with Sacubitril/Valsartan: Insights from a Veterans Administration Healthcare SystemJamie Han, Francisco Chung, Quyen L Nguyen, et al.
Drugs - Real World Outcomes|August 1, 2024
Exploring the Association Between Heart Rate Control and Rehospitalization: A Real-World Analysis of Patients Hospitalized with Heart Failure with Reduced Ejection FractionFreny Vaghaiwalla Mody, Ravi K Goyal, Mayank Ajmera, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 28, 2026
Genetic Diversity and Molecular Mechanisms in Hypertrophic Cardiomyopathy: Toward Personalized TherapyKomal Marwaha, Behram Mody, Nathan Holland, et al.
The Annals of Pharmacotherapy|August 12, 2015
Impact of a Multidisciplinary Heart Failure Post-hospitalization Program on Heart Failure Readmission RatesCynthia A Jackevicius, Noelle K de Leon, Lingyun Lu, et al.
American Journal of Health Behavior|February 24, 2004
Comparative testing of 5 nicotine systems: initial use and preferencesNina G Schneider, Richard E Olmstead, Mitchell Nides, et al.
Clinical Therapeutics|May 27, 2017
Impact of a Multidisciplinary Heart Failure Postdischarge Management Clinic on Medication AdherenceLingyun Lu, Cynthia A Jackevicius, Noelle K de Leon, et al.
Annals of Internal Medicine|September 4, 2023
Evidence-Based Cardiovascular Disease Medicines' Availability in Low-Cost Generic Drug Programs in the United States : A Cross-Sectional StudyIvy T Ton, Jungyeon Moon, Anthony Sengul, et al.
Circulation. Cardiovascular Quality and Outcomes|September 1, 2021
Prior Authorization, Copayments, and Utilization of Sacubitril/Valsartan in Medicare and Commercial Plans in Patients With Heart Failure With Reduced Ejection FractionAya F Ozaki, Harlan M Krumholz, Freny Vaghaiwalla Mody, et al.
Contemporary Clinical Trials|August 26, 2022
The design of the Dashboard Activated Services and Telehealth for Heart Failure (DASH-HF) study: A pragmatic quality improvement randomized implementation trial for patients with heart failure with reduced ejection fractionAradhana Verma, Gregg C Fonarow, Jeffrey J Hsu, et al.
Pageof 2